Archive for the ‘Berkeley spinoffs’ Category

Genocea Biosciences (Berkeley, Harvard) Closes $35 Million Series B Financing (01/03/2011)

April 11, 2011

Genocea Biosciences develops vaccines based on a platform that reduces the time to discover vaccine candidates. Among the company’s co-founders are Darren Higgins, Ph.D. Professor of Microbiology and Molecular Genetics and David Sinclair, Ph.D., Professor of Pathology, both at Harvard Medical School. The company was founded based on developments at both Berkeley and Harvard.

From the company’s press release:
Genocea Biosciences Inc., a vaccine discovery and development company pioneering a new class of T cell-based vaccines, today announced that it has closed a $35 million Series B round of venture financing, with new investors Johnson & Johnson Development Corporation (JJDC), Skyline Ventures and MP Healthcare Venture Management, Inc. (MPH) joining existing investors Polaris Venture Partners, Lux Capital Management, SR One, Cycad Group, Auriga Partners and Morningside Ventures. Stephen J. Hoffman, M.D., Ph.D., managing director at Skyline Ventures, joins the Genocea board in connection with the financing. In addition, Genocea also announced the appointment of industry veteran Seth Hetherington, M.D., to chief medical officer. read full press release

Fluxion Biosciences (Berkeley) Announces Product Launch of BioFlux™ 1000Z (12/7/2010)

December 13, 2010

Fluxion Biosciences produces tools for cellular analyses. The company was founded in 2005 based on dissertation work by Michelle Khine, Ph.D., when she was a graduate student in Professor Luke Lee’s lab at UC Berkeley. Dr. Khine is currently an Assistant Professor of Biomedical Engineering and Chemical Engineering and Material Science at UC Irvine. Cristian Ionescu-Zanetti, Ph.D., who was a post-doctoral researcher in Professor Luke Lee’s lab, serves as Fluxion’s CTO.

From the company’s press release:
Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell Biology Annual Meeting to be held December 11-15, 2010 in Philadelphia, PA. The BioFlux 1000Z is the latest addition to the BioFlux product family of instruments for cellular analysis under controlled shear flow. read full press release

Sensys Networks, Inc. (Berkeley) Releases Arterial Travel Time 2.0 (12/6/2010)

December 13, 2010

Sensys Networks develops wireless traffic detection and integrated traffic data systems. The underlying technology for the company was developed by Caltrans’ Division of Research and Innovation and the Partners for Advanced Transit and Highways (PATH) at the UC Berkeley Institute of Transportation Studies.

From the company’s press release:
Sensys Networks, Inc., the world’s leading provider of wireless traffic detection and integrated traffic data systems, announces the release of Arterial Travel Time 2.0 (ATT). Capitalizing on the success of the system’s initial release, ATT 2.0 further simplifies the end-user experience, while delivering a highly flexible, wireless, universal platform for arterial management. read full press release

KineMed (Berkeley) Reports Clinical Data on Novel Method for Identifying and Verifying Biomarker Candidates in Cerebral Spinal Fluid for Parkinson’s Disease to the Michael J. Fox Foundation (11/30/2010)

December 13, 2010

KineMed Inc. is a biotechnology company developing a platform of translatable metrics revealing the activity of key Causal Pathways in diseases. One of the company’s co-founders is Marc K. Hellerstein, M.D., Ph.D. who is on the faculty of UC Berkeley as well as serving as the Chairman of the KineMed’s Scientific Advisory Board.

From the company’s press release:
KineMed Inc. presented data on new cerebrospinal fluid (CSF) biomarkers reflecting altered brain chemistry, specifically microtubule-mediated neuronal transport of vesicular cargo molecules in Parkinson’s disease, a debilitating neurological condition with considerable unmet therapeutic needs. These biomarkers have uses for monitoring of disease progression and advancement of therapeutic interventions in Parkinson’s disease and other neurodegenerative disorders. read full press release

Alien Technology Corporation (Berkeley) Names Peter Green Chief Executive Officer (11/23/2010)

December 13, 2010

Alien Technology provides UHF Radio Frequency Identification products and services. The company was founded in 1994 by Dr. Stephen Smith, who is currently CTO of the company and Professor of Electrical Engineering (on leave) at the University of California at Berkeley.

From the company’s press release:
Alien Technology Corporation today announced that the company’s Board of Directors has appointed Peter Green to the position of Chief Executive Officer and member of the company’s Board of Directors. read full press release

Discera’s (Berkeley, Michigan) Silicon Oscillators Are The First To Deliver 10 ppm Accuracy For Consumer Applications (11/22/2010)

December 13, 2010

Discera, Inc. develops and markets MEMS-based timing solutions that replace traditional quartz crystals and oscillators. The company was formed in 2001 to commercialize research from the University of Michigan and the University of California at Berkeley. The doctoral work of Chief Technology Officer and Michigan graduate Dr. Wan-Thai Hsu led to the birth of Discera.

From the company’s press release:
Discera, Inc., the leading provider of silicon timing technology announced the production availability of 10 ppm versions of its DSC1001 low jitter and the DSC8001 programmable silicon oscillators. These oscillators are the first silicon timing products to deliver 10 ppm accuracy at up to 85 degrees Celsius as required by ultra-compact and mobile consumer electronics and computing products. They are also the first to deliver this level of performance in a consumer grade product to improve the quality and stability of high definition video applications and wireless communications. Up until now, 10 ppm was only possible for expensive and high power enterprise and carrier grade timing devices. read full press release